Oct. 16--Steven Curley, M.D., promises to be well-prepared if he meets with Food & Drug Administration officials as expected in early 2014 to discuss John Kanzius' cancer-killing machine
Curley, lead investigator for Kanzius' external radio-frequency generator, said he would take research data on both types of treatments his staff has been working on at M.D. Anderson Cancer Center in Houston.
One type uses the late Millcreek Township inventor's radio-frequency device with nanoparticles, microscopic pieces of metal, injected into cancer cells. The other uses the device without nanoparticles but in combination with low doses of traditional chemotherapy drugs.
"We will give the FDA information on both," Curley said during a phone interview today. "The FDA might say the nanoparticles are too complex and they would rather see us go with the chemo. We'll be prepared."
Curley talked a day after Kanzius Cancer Research Foundation officials announced the Kanzius device works on larger animals and that a request will be made to the FDA to begin human trials. The FDA must approve any medicine or device before it can be used to treat humans.
(c)2013 the Erie Times-News (Erie, Pa.)
Visit the Erie Times-News (Erie, Pa.) at www.GoErie.com
Distributed by MCT Information Services